The combined effect on gastric emptying could increase gastrointestinal side effects, and there is no clinical data on the safety of combining GLP-1 Complete specifically with semaglutide or tirzepatide
475,480,481 The encouraging results obtained with semaglutide in patients with heart failure and a preserved ejection fraction may provide a new option for this patient population, in which additional therapy, as well as another upstream therapy for patients with a higher BMI who have indications for this condition, is urgently needed
Yao H, Zhang A, Li D, et al
However, site consistency matters
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society